Viant Technology (DSP) reported earnings on Wed 11 March 26 (a/h)

Viant was launched by brothers Tim, Chris and Russ Vanderhook in 1999. The company acquired social networking company Myspace in 2011. Later that year it helped start connected TV platform Xumo, which was acquired by Comcast in 2020.

• Sector: Technology
• Industry: Software - Application
• https://www.viantinc.com
• Founded in 1999
• Headquartered in Irvine, CA

IPO Feb 10, 21; ticker DSP

Chris and Tim Vanderhook, COO and CEO of Viant

Viant posts record Q4 2025 with EPS $0.31 (+210% YoY) and revenue $64.6M (+19% YoY), beating guidance and estimates, launches AI Outcomes product

• Q4 revenue and contribution ex-TAC beat guidance, with ex-political growth accelerating sharply.
• Full-year 2025 revenue and adjusted EBITDA exceeded guidance with high-teens growth and nearly 250 bps EBITDA margin expansion.
• Upbeat Q1 2026 guide implies ~20% revenue growth but slower Q4-like momentum seasonally.
• Management expects sequential growth acceleration through 2026 from new clients, Outcomes, and political.

The company, which has about 300 employees, competes with players like The Trade Desk and with part of Google’s ad tech business. The software is used by marketers and their ad agencies to centralize buying, planning and measurement of advertising across channels like desktop, mobile, connected TV, streaming audio and digital billboards.

Ero Copper (ERO) +17%

Ero Copper Corp. engages in the exploration, development, and production of mining projects in Brazil. 

Its flagship asset includes Caraíba operations that comprise the production and sale of copper concentrates located in northeastern Bahia State, Brazil, as well as gold and silver produced and sold as by-products. 

• Sector: Basic Materials
• Industry: Copper
• Full Time Employees: 3,690
• Incorporated in 2016 
• Headquartered in Vancouver, Canada
• https://erocopper.com

Edible Garden (EDBL) : 3-year performance

 

 

 

AirSculpt Technologies (AIRS) reported earnings on Fri 2 May 25 (b/o)

AirSculpt Technologies provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

• Sector: Healthcare
• Industry: Medical Care Facilities
• Full Time Employees: 389
• Founded by Aaron J. Rollins in 2012  
• Headquartered in Miami Beach, Florida
• https://airsculpt.com

Ticker: AIRS

** charts after earnings **

 

 

First Quarter 2025 Results

• Case volume was 3,076 for the first quarter of 2025, representing a 17.9% decline from the fiscal year 2024 first quarter case volume of 3,746;
• Revenue declined 17.3% to $39.4 million from $47.6 million in the fiscal year 2024 first quarter;
• Net loss for the quarter was $2.8 million compared to net income of $6.0 million in the fiscal year 2024 first quarter; and Adjusted EBITDA was $3.8 million compared to $7.3 million for the fiscal year 2024 first quarter.

2025 Outlook

The Company projects full year 2025 revenue and adjusted EBITDA guidance as follows:

• Revenues of approximately $160 to $170 million
• Adjusted EBITDA of approximately $16 to $18 million

GeneDx (WGS) reported earnings on Tue 18 Feb 25 (b/o)

• Sema4 (SMFR); IPO 23 Jul 21; rebranded GeneDx (WGS)  (January 10, 2023)

** charts after earnings ** 

Strong Beat, Guidance: This provider of exome and genome tests is a play on the shift toward personalized medicine and earlier intervention.

During the fourth quarter, GeneDx earned an adjusted 77 cents per share, obliterating forecasts for 16 cents, according to FactSet. Earnings flipped from a year-earlier loss of 49 cents. Sales grew almost 65% to $95.6 million, well ahead of calls for $82.2 million.

GeneDx also guided to $350 million to $360 million in full-year sales. The low end of the outlook easily beat analysts' forecast for $340.4 million.

GeneDx uses AI to provide genomics-related diagnostic testing.

GeneDx provides whole genome and exome sequencing to help identify rare diseases, primarily in children. The genome includes all the DNA in the body, while reading the exome involves looking at only the protein-coding genes.

When performed early, genetic testing can lead to answers that help avoid what Chief Executive Katherine Stueland calls a "diagnostic odyssey." The company only tests for diseases where there is a solution — a clinical study, a dietary change or a treatment.

Absci (ABSI) : 4-year performance

 

 

Palladyne AI (PDYN) : 3-year performance

Palladyne AI Corp. is an American company known for most of its existence primarily as a developer of robots. 

• Palladyne was founded in 1983 as Sarcos Research Corporation. 

• Sarcos Research (STRC) went public on Sept 27, 2021 via business combination with Rotor Acquisition Corp.
• 
  In 2023, Sarcos "pivoted" to become a developer of artificial-intelligence software, specifically for robotic applications. This pivot was accompanied by a cessation of all operations involving hardware. 
• In March 2024, Sarcos changed its name to Palladyne AI.  The company’s ticker symbols have changed from Nasdaq: STRC to Nasdaq: PDYN.

Sector: Technology

Industry: Software - Infrastructure

Full Time Employees: 70

Headquartered in Salt Lake City, Utah

https://www.palladyneai.com

60 Degrees Pharmaceuticals (SXTP) : 18-month performance

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. 

• Sector:  Healthcare
• Industry: Biotechnology
• Full Time Employees:  3
• founded in 2010 
• Headquartered in Washington, District Of Columbia
• https://www.60degreespharma.com

IPO: Fri 14 July 2023

60 Degrees Pharmaceuticals (NASDAQ: SXTP) focuses on developing and commercializing medicines for infectious and vector-borne diseases. Their lead drug is ARAKODA® (tafenoquine), an FDA-approved oral medication (approved in 2018) for malaria prevention in adults, marketed in the US and Australia. It's a once-weekly regimen and their primary commercial product.The company's pipeline centers on repurposing tafenoquine for new indications, particularly babesiosis (a tick-borne parasitic infection), alongside earlier-stage efforts in other areas.

Absci (ABSI) : 3-year performance

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 140
• Founded by Sean McClain in 2011 
• Headquartered in Vancouver, Washington
• https://www.absci.com

IPO: July 22, 2021; shares priced at $16

Ticker: ABSI 

 

 

 

 

 

KULR Technology Group (KULR): 3-year performance

• Sector: Technology
• Industry: Electronic Components
• https://www.kulrtechnology.com

 

 

Vertical Aerospace (EVTL) : 3-year performance

Vertical Aerospace Ltd. is a global aerospace and technology company. It engages in the business of designing, manufacturing, and selling a zero operating emission electric vertical takeoff and landing aircraft for use in the advanced air mobility market using the most cutting-edge technology from the aerospace, automotive, and energy industries.

• Sector: Industrials
• Industry: Aerospace & Defense
• Full Time Employees: 350
• founded by Stephen James Fitzpatrick in 2016 
• headquartered in Bristol, the United Kingdom
• https://www.vertical-aerospace.com

December 16, 2021: went public via a business combination with Broadstone Acquisition Corp. 

 

 

 

 

One month later:

 

 

 

Navitas Semiconductor (NVTS) : 3-year performance

• Sector: Technology
• Industry: Semiconductors
• Full Time Employees: 280
• Founded in 2014 
• Based in Torrance, California
• https://navitassemi.com

IPO: October 20, 2021; Navitas Semiconductor went public through a SPAC merger with Live Oak Acquisition Corp. II

Zeta Global (ZETA) : 4-year performance

Zeta Global Holdings Corp. is an American marketing technology company which offers companies a suite of multichannel marketing tools focused on creating, maintaining, and monetizing customer relationships.

• Sector(s): Technology
• Industry: Software - Infrastructure
• Founded in 2007
• Headquartered in New York, New York
• Full Time Employees: 1,783
• https://www.zetaglobal.com